Hypertrophic cardiomyopathy

Description

Hypertrophic cardiomyopathy is the presence of a hypertrophied, non-dilated ventricle in the absence of a hemodynamic cause that is capable of producing the existent magnitude of wall thickening excluding both physiologic hypertrophy secondary to physical activity, and pathologic hypertrophy due to systemic hypertension, aortic valvar stenosis, and coarctation.

Exclusions from above levels

BC42 – Myocarditis
01 – Certain infectious or parasitic diseases
05 – Endocrine, nutritional or metabolic diseases

Show allHide

18 – Complications of pregnancy, childbirth and the puerperium
19 – Certain conditions originating in the perinatal period
20 – Congenital malformations, deformations and chromosomal abnormalities
22 – Injury, poisoning or certain other consequences of external causes

Child codes

BC43.10 – Familial-genetic hypertrophic cardiomyopathy
BC43.11 – Non-obstructive hypertrophic cardiomyopathy
BC43.12 – Obstructive hypertrophic cardiomyopathy
BC43.1Y – Other specified hypertrophic cardiomyopathy
BC43.1Z – Hypertrophic cardiomyopathy, unspecified

Foundation children elsewhere

KB60.1 – Syndrome of infant of a diabetic mother, type 1 or 2, nongestational, insulin dependent

Sibling codes

BC43.0 – Dilated cardiomyopathy
BC43.2 – Restrictive cardiomyopathy
BC43.3 – Endocardial fibroelastosis
BC43.4 – Cardiomyopathy due to drugs or other external agents
BC43.5 – Stress-induced cardiomyopathy
BC43.6 – Arrhythmogenic ventricular cardiomyopathy
BC43.7 – Diabetic cardiomyopathy
BC43.Y – Other specified cardiomyopathy
BC43.Z – Cardiomyopathy, unspecified

Foundation entity

Hypertrophic cardiomyopathy – http://id.who.int/icd/entity/1830681485

Allowed postcoordination axes

hasManifestation

Part of: BC43: Cardiomyopathy › 11: Diseases of the circulatory system